Safety of apixaban and rivaroxaban compared to warfarin after cardiac surgery

ConclusionApixaban and rivaroxaban demonstrated similar safety when compared to a matched cohort of warfarin patients. Larger prospective randomized studies are needed to confirm these findings.

Source: Journal of Cardiac Surgery - December 8, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Kushal D. Naik, Bryan A. Whitson, Eric M. McLaughlin, Nancy B. Matre, Alan J. Rozycki Tags: ORIGINAL ARTICLE Source Type: research